MAY 04, 2021 2:06 PM PDT

Micro-dosing Inhaler Breakthrough for Medical Cannabis

WRITTEN BY: Angela Dowden

In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is able to provide exact microdoses of cannabis more safely.

The inhaler was developed by Syqe Medical, with funding from the Israel Innovation Authority, and use of  half-million-dollar 3D printer for free as a beta product. It has been tested as a way to administer THC in pain patients in Israel, where users report quality of life improvements and fewer psychoactive and undesirable side effects.

The company’s research results published in the European Journal of Pain, showed that patients experienced a 90 percent reduction in adverse effects associated with cannabis in comparison to other administration methods such as oil, smoking and vaping. Strikingly the optimal dose to reduce pain was only around 500 micrograms inhaled three times a day — much lower that the amount of THC normally vaped.

Following their success in Canada, Syqe are now working to introduce their product at home in Israel. The company is also seeking regulatory approval in the US and several other European countries.

"The approval in Canada would not have been possible without the 10 years of technological development and clinical trials, demonstrating that low doses alongside high precision delivery result in the optimal cannabis treatment,” Syqe Medical’s CEO and founder, Perry Davidson, told the Jerusalem Post.

Specific doses in increments as small as 100 micrograms can be delivered by using dedicated thermal controllers and lung monitoring systems that automatically adjust airflow. The inhaler is also capable of transmitting usage data to help researchers.

The Syqe cannabis inhaler recently obtained the EU’s CE quality kitemark for health, safety, and environmental protection, but Canada is the first national healthy authority to approve the device. Regulatory approvals are now being sought in Israel, the US and several European countries.

 

Sources: Merry Jane, The Jerusalem Post

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
OCT 06, 2021
Technology
New Sensor Could Detect Antibiotics In Your Breath
OCT 06, 2021
New Sensor Could Detect Antibiotics In Your Breath
Antibiotics are the cornerstone of treatment for bacterial infections. Though antibiotic resistance caused by the incorr ...
OCT 07, 2021
Neuroscience
Unclogged: Constipation Drug May Stimulate Memory and Cognition
OCT 07, 2021
Unclogged: Constipation Drug May Stimulate Memory and Cognition
A drug commonly prescribed for constipation shows promise for memory and cognition
OCT 09, 2021
Cardiology
Elevated Blood Pressure Linked to Decline in Brain Health
OCT 09, 2021
Elevated Blood Pressure Linked to Decline in Brain Health
New research has confirmed previous work indicating that there's a connection between elevated blood pressure and cognit ...
OCT 15, 2021
Health & Medicine
Over Half of Patients Infected in the Pandemic Experience 'Long COVID'
OCT 15, 2021
Over Half of Patients Infected in the Pandemic Experience 'Long COVID'
About 236 million people are known to have been infected with SARS-CoV-2, the virus that causes COVD-19. Researchers hav ...
OCT 15, 2021
Drug Discovery & Development
Oxytocin Therapy Shows No Benefit for Autistic Children
OCT 15, 2021
Oxytocin Therapy Shows No Benefit for Autistic Children
Intranasal oxytocin therapy does not benefit autistic children and adolescents. The corresponding study was published in ...
Loading Comments...